Market Highlights:
The vitals and reagents provided for collecting samples and delivering them to the laboratory where the testing services will be performed on such a sample are referred to as the sample collection kit. The rising demand for sample collection kits as a result of the global epidemic of COVID-19, as well as government approval of new and enhanced detection tests, are likely to propel the COVID-19 sample collection kits market forward.

According to MRFR analysis, the Global COVID-19 Sample Collection Kits Market Report is expected to register a CAGR of 5.20% during the forecast period of 2020 to 2027 and reach USD 4168.35 Million by 2027.

The product is a nasal swab sample collection kit that can be used at home and shipped to specific labs for COVID-19 diagnostic testing. As a result, demand for sample collecting kits is increasing. Furthermore, the COVID-19 sample collecting kits market is predicted to grow because to the detection of antibodies, increased government financing, huge volume of products, and high swab usage rate. Furthermore, an increase in antibody detection, an increase in government financing, and a large volume of products and swab usage rate are likely to drive market expansion throughout the projection period.

However, a scarcity of laboratory-based reagents and a shortage of test-related supplies such as reverse transcription-polymerase chain reaction instruments, swabs, and virus control samples to control COVID-19 are likely to limit the worldwide COVID-19 sample collection kits market's growth.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/9769

Regional Analysis

The COVID-19 sample collecting kits market has been divided into three categories: product type, application, and end user.
The market has been divided into swabs, viral transport medium, blood collection kits, and others based on product type. The swabs category is expected to increase at the fastest rate. Swabs are classified into two types: nasopharyngeal swabs and oropharyngeal swabs. Only nasopharyngeal swabs should be collected for testing, according to the Centers for Disease Control and Prevention (CDC). The fastest-growing segment is viral transportation media. The need for blood collection kits, on the other hand, is increasing as blood-based serology testing/antibody detection tests for SARS-CoV-2 are approved.

The market has been divided into diagnostic and research segments based on application. The diagnostic segment is predicted to expand at the fastest rate, while the research segment is expected to grow at the fastest rate. In terms of revenue creation, the research segment has a low penetration in the global market. However, the market is predicted to grow due to a growth in the number of R&D programs that use sample collection kits to assess the efficacy of various diagnostic procedures.

The market has been divided into hospitals and clinics, diagnostics centers, and others based on the end user. The diagnostic center is expected to increase at the fastest rate. The largest segment is hospitals and clinics, with a growing need for COVID-19 testing in communities. To keep the illness from spreading, many sealed cabins have been set up for collecting swab samples. This is the fastest-growing segment of the market.

Segmentation

The global COVID-19 sample collection kits market has been segmented based on the product type, application, and end user.

On the basis of product type, the market has been segmented into swabs, viral transport media, blood collection kits, and others. The swabs segment is anticipated to be the fastest-growing segment. The swab segment is further divided into nasopharyngeal swabs and oropharyngeal swabs. The Centers for Disease Control and Prevention (CDC) has recommended collecting only nasopharyngeal swabs for testing the sample. The viral transport media is the largest growing segment. 

Based on application, the market has been segmented into diagnostic, and research. The diagnostic segment is expected to be the fastest-growing, while the research segment is the largest growing segment.

The market based on end user has been segmented into hospitals & clinics, diagnostics centers, and others. The diagnostic center is anticipated to be the fastest-growing segment. The largest growing segment is hospitals & clinics.

Key Players:

Some of the key players in the global COVID-19 sample collection kits market are Thermo Fisher Scientific, Inc. (US), Hardy Diagnostics (US), BNTX Inc. (Germany), Formlabs (US), Medline Industries, Inc. (US), HiMedia Laboratories (India), VIRCELL S.L. (Spain), Puritan Medical Products (US), COPAN Diagnostics (California), Becton, Dickinson, and Company (US), Laboratory Corporation of America Holdings (US), Lucence Diagnostics Pte Ltd. (California)

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/covid-19-sample-collection-kits-market-9769

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com